Diseases & Disorders
(G96)
IRS Verified
DX Registered
990 on File
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Financial strength (30%)
85/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$19.5M
Total Revenue
$18.0M
Total Expenses
$21.1M
Net Assets
54
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
76.6%
Fundraising Efficiency
22655.1%
Operating Reserve
14.08x
Liability-to-Asset
19.0%
Revenue Diversification
61.1%
Executive Compensation
$769K
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
76.6% | 85.4% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
14.6% | 11.1% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.9% | 1.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
22655.1% | 368.9% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.1 mo | 10.0 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
19.0% | 23.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
61.1% | 92.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
16.7% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
9.0% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
7.5% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $19.5M | $18.0M | $21.1M | 76.6% | 54 |
| 2024 | $16.7M | $16.5M | $18.9M | 76.0% | 50 |
| 2023 | $18.2M | $16.7M | $16.8M | 78.7% | 52 |
| 2022 | $15.8M | $12.3M | $14.7M | 74.4% | 46 |
| 2021 | $11.4M | $9.5M | N/A | — | 45 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.